Form 4: Intuitive Surgical Executive Jamie Samath Reports Stock Option Exercises and Sales
SEC Form 4
Jamie Samath, an executive at Intuitive Surgical, executed stock options and sold shares according to a pre-arranged trading plan.
Summary
- On May 2, 2025, Jamie Samath, EVP & CFO & Enterprise Technology Leader at Intuitive Surgical Inc. (ISRG), engaged in multiple transactions involving the company's common stock.
- Samath exercised non-qualified stock options to acquire a total of 915 shares at prices ranging from $208.9 to $304.67.
- Concurrently, Samath sold 915 shares of common stock at a price of $527.95.
- These transactions were executed under a pre-arranged trading plan complying with SEC Rule 10b5-1, set to expire on May 6, 2025.
- Following these transactions, Samath directly owns 7,162 shares of Intuitive Surgical common stock.
- Samath also holds options to purchase thousands of additional shares at various exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing of stock transactions by an executive under a pre-arranged plan. There's no indication of unusual activity or cause for alarm, but also no specific positive news.
Positives
- The transactions were executed under a pre-arranged trading plan, suggesting they were planned and not based on immediate insider information.
Negatives
- The sale of shares by an executive could be perceived negatively by some investors, although it's part of a pre-planned strategy.
Risks
- Executive stock sales can sometimes be misinterpreted by the market, potentially leading to short-term price volatility.
- Changes in executive holdings are always subject to scrutiny and can influence investor sentiment.
Future Outlook
The document does not contain any specific forward-looking statements about the company's future performance.
Industry Context
Executive stock transactions are a normal part of corporate governance and compensation practices in the medical device industry. Investors often monitor these transactions for insights into management's perspective on the company's value.
Comparison to Industry Standards
- Executive compensation packages in the medical device industry often include stock options as a significant component.
- Companies like Stryker (SYK) and Medtronic (MDT) also utilize stock options as part of their executive compensation plans.
- The vesting schedules and exercise prices of Intuitive Surgical's stock options are generally in line with industry standards for incentivizing long-term performance.
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
- The transactions have no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| February 10, 2023 | Date used to measure vesting for some stock options. |
| August 10, 2023 | Date used to measure vesting for some stock options. |
| August 28, 2029 | Expiration date for some stock options. |
| February 27, 2030 | Expiration date for some stock options. |
| August 9, 2030 | Expiration date for some stock options. |
| 05/02/2025 | Date of stock option exercise and stock sale. |
| 05/05/2025 | Date of Form 4 filing. |
| May 6, 2025 | Expiration date of the Rule 10b5-1 trading plan. |
Keywords
Intuitive Surgical, ISRG, Jamie Samath, stock options, Form 4, insider trading, Rule 10b5-1, executive compensation, stock sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.